GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Clinical trials have found that people who are on the prescription for a year can lose more than 10% of their body weight.

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.

Weight loss drugs continue to make headlines.  A new study conducted by researchers from the University of Southern California looked at a positive side

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both generic and compounded drugs for quality and safety

Millions of Americans use GLP-1 injections like Ozempic to lose weight. A study is questioning whether they can cause vision loss.